https://www.aidsmap.com/ en https://www.aidsmap.com/news//news/jun-2026/worse-hiv-control-diagnosis-doesnt-mean-worse-lymphoma-outcomes The outcomes of lymphoma – one of the most common types of cancer in people with HIV – seem to be largely uninfluenced by viral suppression at the time of diagnosis. Although people with detectable viral load had lower CD4 counts and more advanced lymphoma when diagnosed, their chances of remission and survival were similar to those of people whose HIV was suppressed. Zekerie Redzheb https://www.aidsmap.com/news//news/jun-2026/worse-hiv-control-diagnosis-doesnt-mean-worse-lymphoma-outcomes Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/jun-2026/switching-integrase-inhibitor-can-raise-diabetes-risk-people-hiv Two large studies have found that switching to an integrase inhibitor carries a moderately increased risk of developing type 2 diabetes for some groups of people with HIV. In one study, which combined data from 27 cohorts of people receiving HIV care in North America, switching from a protease inhibitor to an integrase inhibitor increased the risk of developing type 2 diabetes within two years. Switching from a non-nucleoside reverse transcriptase inhibitor to an integrase inhibitor did not raise the risk of developing diabetes. Keith Alcorn https://www.aidsmap.com/news//news/jun-2026/switching-integrase-inhibitor-can-raise-diabetes-risk-people-hiv Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/jun-2026/bepirovirsen-leads-functional-cure-one-fifth-people-long-term-hepatitis-b One in five people with chronic (long term) hepatitis B who were treated with the investigational agent bepirovirsen were functionally cured and no longer needed to take daily antiviral therapy, according to late-stage study results presented last week at the European Association for the Study of the Liver (EASL) Congress in Barcelona and published in The New England Journal of Medicine. Liz Highleyman https://www.aidsmap.com/news//news/jun-2026/bepirovirsen-leads-functional-cure-one-fifth-people-long-term-hepatitis-b Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/may-2026/injectable-prep-leeds-and-london-criteria-approval-and-continuation In February this year, the UK government announced that it was expanding NHS England’s initial rollout of long-acting injectable HIV PrEP to 2000 people rather than the 1000 it initially announced last November. Gus Cairns https://www.aidsmap.com/news//news/may-2026/injectable-prep-leeds-and-london-criteria-approval-and-continuation Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/may-2026/greater-risk-schizophrenia-among-people-hiv-especially-those-who-inject-drugs While the risk of being diagnosed with schizophrenia was higher among all people with HIV in a large Danish cohort, those who acquired HIV through injecting drug use were at a much higher risk. This research also highlights the complex familial factors that may play a role in being diagnosed with schizophrenia. Krishen Samuel https://www.aidsmap.com/news//news/may-2026/greater-risk-schizophrenia-among-people-hiv-especially-those-who-inject-drugs Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/may-2026/syphilis-cases-increasing-women-uk While the majority of cases of syphilis in the UK are still in gay and bisexual men who have sex with men and transgender women, the proportion of cases in heterosexuals and particularly women has risen in the last decade. Gus Cairns https://www.aidsmap.com/news//news/may-2026/syphilis-cases-increasing-women-uk Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/may-2026/uk-sexual-health-conference-debates-move-less-frequent-sti-screening One of the last sessions of the recent joint conference of the British HIV Association (BHIVA) and the British Association of Sexual Health and HIV (BASHH) covered BASHH’s most recent clinical guidelines. Gus Cairns https://www.aidsmap.com/news//news/may-2026/uk-sexual-health-conference-debates-move-less-frequent-sti-screening Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/may-2026/people-living-hiv-join-outreach-teams-re-engagement-care-moves-political-agenda Programmes to find people who have dropped out of HIV care in England and to re-engage them with medical care are beginning to harness the expertise of peer support workers, the joint conference of the British HIV Association (BHIVA) and the British Association of Sexual Health and HIV (BASHH) heard last week in Liverpool. Roger Pebody https://www.aidsmap.com/news//news/may-2026/people-living-hiv-join-outreach-teams-re-engagement-care-moves-political-agenda Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/toronto-man-cured-hiv-after-stem-cell-transplant A Canadian man appears to be free of HIV after a stem cell transplant using cells from an HIV-resistant donor, potentially making him the eleventh person to be cured after the procedure, researchers reported this week at the Canadian Association of HIV Research Conference. Stem cell transplants are too risky for people living with HIV who do not have advanced cancer, but each new case offers clues that could help scientists develop an accessible functional cure, or long-term remission without antiretroviral treatment. Liz Highleyman https://www.aidsmap.com/news//news/apr-2026/toronto-man-cured-hiv-after-stem-cell-transplant Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/future-aidsmap aidsmap started with a simple but powerful idea – that the latest information about HIV should be easily available for healthcare providers and able to be shared with someone with HIV and their friends and family. For decades, that commitment made aidsmap a critical resource for many of the expert patients who transformed care for people living with HIV – and reshaped the relationship between health services and those they serve. https://www.aidsmap.com/news//news/apr-2026/future-aidsmap Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/doxypep-halves-overall-syphilis-cases-possible-indirect-benefits-women Doxycycline post-exposure prophylaxis in Seattle is linked to a halving of syphilis diagnoses overall and a reduction of cases by a third in transgender people. Despite very low uptake, women also experienced a significant drop in syphilis cases, likely partly explained by reduced syphilis transmission within the communities where doxyPEP is being used. Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/doxypep-halves-overall-syphilis-cases-possible-indirect-benefits-women Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/wanted-new-writers-aidsmap Applications have now closed. aidsmap has long been one of the world's leading sources of accurate, independent HIV information. After a period of uncertainty, aidsmap is back – and one of our priorities is reviving Emerging Voices, a programme to train and support a new generation of aidsmap writers. I'm personally thrilled that we are doing this, and I'd love to hear from you if you're looking to develop your scientific writing and become part of our team. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/wanted-new-writers-aidsmap Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/they-are-already-dead-how-outdated-knowledge-and-cruel-stereotypes-contribute A qualitative study of adolescents living with HIV in Malawi has found that outdated beliefs about HIV, and stereotypes of people with it, contribute to pervasive and persistent stigma against young people living with the virus. This does not only have adverse psychological effects but disadvantages them in practical ways, damaging their educational and employment prospects. Gus Cairns https://www.aidsmap.com/news//news/apr-2026/they-are-already-dead-how-outdated-knowledge-and-cruel-stereotypes-contribute Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/top-5-stories-threats-global-hiv-response-croi-2026 The withdrawal of US funding for global HIV programmes was a defining theme at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver in February. Researchers and advocates grappled with both the immediate damage and the longer-term outlook. Here are five key stories from the conference. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/top-5-stories-threats-global-hiv-response-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/top-5-stories-hiv-prevention-and-sexual-health-croi-2026 From a contested study on U=U to a disappointing gonorrhoea vaccine trial and the ongoing global PrEP crisis, HIV prevention was a key topic at this year's Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver. Here are five highlights. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/top-5-stories-hiv-prevention-and-sexual-health-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/top-5-stories-search-hiv-cure-croi-2026 The search for a way to control HIV without antiretroviral therapy (ART) continued to generate both promising signals and sobering setbacks at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver. Here are five highlights. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/top-5-stories-search-hiv-cure-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/top-5-stories-hiv-response-africa-croi-2026 Africa is home to the majority of people living with HIV and the region hardest hit by the donor funding crisis. At this year's Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, there was promising science – from community-level prevention to cure research with children. Here are five highlights. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/top-5-stories-hiv-response-africa-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/apr-2026/top-5-stories-long-term-health-people-living-hiv-croi-2026 As more people live longer with HIV, managing other health conditions is increasingly important. Research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver covered a wide range of issues – from new obesity drugs and cardiovascular risk to transplant outcomes and stimulant drug use. Here are five highlights. Roger Pebody https://www.aidsmap.com/news//news/apr-2026/top-5-stories-long-term-health-people-living-hiv-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/mar-2026/top-5-stories-future-hiv-treatment-croi-2026 The HIV treatment landscape is changing fast. Research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver pointed towards a future of fewer pills, less frequent dosing and new drug classes – from twice-yearly injectables to a simplified regimen for people on complex treatment. Here are five highlights. Roger Pebody https://www.aidsmap.com/news//news/mar-2026/top-5-stories-future-hiv-treatment-croi-2026 Cancer Viral load Zekerie Redzheb https://www.aidsmap.com/news//news/mar-2026/untapped-potential-cd8-cells-how-cellular-immunity-may-be-key-hiv-cure Several presentations at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US provided hope for the development of therapeutic vaccinations as well as T-cell and antibody therapies that could lead to long-term control or even a cure for HIV. It had been thought that HIV infection, especially long-term infection, exhausts the immune cells that normally fight infections, leading to a state of immune ‘senescence’ (premature ageing) and long-term, low-level inflammation. Gus Cairns https://www.aidsmap.com/news//news/mar-2026/untapped-potential-cd8-cells-how-cellular-immunity-may-be-key-hiv-cure Cancer Viral load Zekerie Redzheb